Ligand Pharmaceuticals (LGND)

Add to Watchlists Create an Alert
51.89 -2.28  -4.21% NASDAQ Aug 21, 2:02PM BATS Real time Currency in USD

Ligand Pharmaceuticals Return on Equity (TTM):

14.31% for June 30, 2014

View 4,000+ financial data types

View Full Chart

Ligand Pharmaceuticals Return on Equity (TTM) Chart

Export Data
Save Image

Ligand Pharmaceuticals Historical Return on Equity (TTM) Data

View and export this data going back to 1994. Start your YCharts Lite Membership
Export Data Date Range:
Viewing of   First  Previous First  Previous   Next  Last Next   Last
Data for this Date Range  
June 30, 2014 14.31%
March 31, 2014 26.22%
Dec. 31, 2013 29.93%
Sept. 30, 2013 32.68%
June 30, 2013 31.08%
March 31, 2013 -0.71%
Dec. 31, 2012 -2.82%
Sept. 30, 2012 22.28%
June 30, 2012 -8.29%
March 31, 2012 15.19%
Dec. 31, 2011 302.7%
Sept. 30, 2011 -3004%
June 30, 2011 -718.2%
March 31, 2011 -223.5%
Dec. 31, 2010 902.9%
Sept. 30, 2010 569.7%
June 30, 2010 -68.35%
March 31, 2010 -6.89%
Dec. 31, 2009 22.58%
Sept. 30, 2009 831.5%
June 30, 2009 2892%
March 31, 2009 -2428%
Dec. 31, 2008 -763.4%
Sept. 30, 2008 -111.7%
June 30, 2008 -11.92%
   
March 31, 2008 10.01%
Dec. 31, 2007 807.6%
Sept. 30, 2007 -1969%
June 30, 2007 -540.8%
March 31, 2007 -305.7%
Dec. 31, 2006 -60.72%
Sept. 30, 2006 25.34%
June 30, 2006 24.64%
March 31, 2006 24.72%
Dec. 31, 2005 37.10%
Sept. 30, 2005 24.10%
June 30, 2005 78.16%
March 31, 2005 1045%
Dec. 31, 2004 -619.1%
Sept. 30, 2004 -331.3%
June 30, 2004 -336.9%
March 31, 2004 -325.8%
Dec. 31, 2003 -293.9%
Sept. 30, 2003 -123.6%
June 30, 2003 -107.2%
March 31, 2003 -106.2%
Dec. 31, 2002 -121.6%
Sept. 30, 2002 -219.5%
June 30, 2002 526.3%
March 31, 2002 116.6%

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Return on Equity (ROE)

Return on equity (ROE) measures the rate of return on the money invested by common stock owners and retained by the company thanks to previous profitable years. It demonstrates a company's ability to generate profits from shareholders' equity (also known as net assets or assets minus liabilities).

ROE shows how well a company uses investment funds to generate growth. Return on equity is useful for comparing the profitability of companies within a sector or industry.

Investors generally are interested in company's that have high, increasing returns on equity.
Learn More

Get data for
Advertisement

LGND Return on Equity (TTM) Benchmarks

Companies
TG Therapeutics -73.83%
Amgen 22.45%
Metabasis Therapeutics

LGND Return on Equity (TTM) Range, Past 5 Years

Minimum -3004% Sep 2011
Maximum 902.9% Dec 2010
Average -61.57%

LGND Return on Equity (TTM) Excel Add-In Codes

  • Metric Code: return_on_equity
  • Latest data point: =YCP("LGND", "return_on_equity")
  • Last 5 data points: =YCS("LGND", "return_on_equity", -4)

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Start My Free Trial"}}

Already a {{root.upsell.info.tier_name}} Member? Sign in here.